Cancer research and clinical care nonprofit operating integrated translational programs
Fred Hutch operates as both an independent research organization and UW Medicine's cancer program, running clinical trials, genomic sequencing work, and therapeutic development across oncology, immunology, and gene therapy. The research-heavy hiring profile (123 active roles in research vs. 117 in healthcare delivery) reflects a dual mission: laboratory-to-clinic translation. Current project focus spans vaccine immunology, liquid biopsy methods, cell and gene therapies, and multi-omic biomarker discovery—all supported by sequencing infrastructure (PacBio, Illumina, Sanger) and statistical analysis tools (R, Python, SAS, Stata).
Notable leadership hires: Program Head, Program Operations Director, Lab Director, Associate Director, Director of Clinical Research
Fred Hutch is an independent nonprofit cancer center headquartered in Seattle that also functions as the cancer program for UW Medicine. The organization spans clinical research (including Phase 1 trials and translational studies), clinical care delivery, and basic science research across immunology, gene therapy, and oncology. Operations are distributed across multiple sites, with active programs in liquid biopsy analysis, cell and gene therapies, vaccine immunology, and multi-cancer detection trials. The org currently staffs 267 open roles with steady hiring velocity, concentrated in research and healthcare functions. All hiring is domestic (United States).
Fred Hutch serves as the independent cancer program for UW Medicine, providing the specialized focus of a top-ranked cancer center alongside the comprehensive services of an integrated health system.
The organization uses PacBio, Illumina, and Sanger sequencing platforms, plus RT-qPCR for molecular analysis, supported by statistical tools including R, Python, SAS, and Stata.
Active projects include vaccine immunology assays, liquid biopsy methods, cell and gene therapies, multi-omic biomarker discovery, multi-cancer detection trials, and cord blood transplant programs.
Other companies in the same industry, closest in size